Clinical OMICs - Volume 3, Issue 9 - 33
Clinical OMICs MEETING ROUNDUP
September 19-21
Festival of Genomics California
San Diego
Festival of Genomics Caifornia is a free-to-attend genomics
meeting and exhibition featuring nine topical tracks including
Genomic Medicine, Cancer Genomics, Enabling Data,
Transcriptomics, Editing the Genome, Single Cell Analysis, and
Drug Development, among others. It also features TechForum,
quick-fire presentations, a special seminar on artificial intelligence
(AI), hands on demonstrations in the Live Lab and an exhibition
floor with more than 50 exhibitors focused on providing tools and
services to the fast growing genomics market.
September 25-28, 2016
Baltimore
The Genomics of Common Diseases 2016
High-throughput genotyping and sequencing technologies
have profoundly impacted our understanding of the genetic
architecture of disease. This year's conference will be an
opportunity to reflect back on the past decade of genomic studies
and to consider how new and emerging technologies will yield
further insights into disease pathophysiology with potential for
clinical impact. The meeting will feature leading examples of
genetic discovery efforts for common diseases using a range of
technologies and study designs. The program will also highlight
approaches to characterize regulatory variation, strategic uses
of experimental systems to increase mechanistic understanding
of disease, and important recent efforts in clinical
translation.
www.clinicalomics.com
October 18-21
World CDx Boston 2016
Boston
World CDx Boston Summit 2016 offers content dedicated to
help industry participants progress from exploratory biomarker
to registrational CDx, align clinical co-development and ensure
reimbursement and market access success for your precision
therapies and assays. With the rise of liquid biopsies, NGS and
other multi-omic technologies, overcome disease heterogeneity
and validate exploratory biomarkers to accurately stratify your
therapy and future CDx. The conference offers different learning
streams including the Biomarker Discovery & Validation Stream,
the Clinical Co-Development Stream, and the Precision Medicine
Commercialization Stream. Through senior level networking and
unrivalled learning, define your most efficient CDx roadmap.
Improve your discovery, development, and commercialization of
biomarker-based precision therapies and assays.
October 18-22
ASHG
Vancouver
The 66th Annual Meeting of the American Society of Human
Genetics is the largest human genetics meeting and exposition
in the world. This year's meeting is expected to attract more than
6,500 scientific attendees, plus 200 exhibiting companies. The
meeting provides a forum for the presentation and discussion
of cutting-edge science in all areas of human genetics. ASHG
members and leading scientists from around the world are
selected to present their research findings at invited, platform,
and poster sessions. Abstracts presented at the Annual Meeting
are published online and are citable. ASHG's Annual
Meeting also features a trade show floor that offers
attendees the opportunity to view state-ofthe-art medical and laboratory equipment,
products, services, and computer software
designed to enhance human genetics
research, teaching, and consultation.
September 2016 Clinical OMICs
33
http://www.festivalofgenomicscalifornia.com/welcome
http://world-cdx.com/
http://www.nature.com/natureconferences/gcd2016/index.html
http://www.ashg.org/2016meeting/
http://www.clinicalomics.com
Table of Contents for the Digital Edition of Clinical OMICs - Volume 3, Issue 9
Contents
Clinical OMICs - Volume 3, Issue 9 - Cover1
Clinical OMICs - Volume 3, Issue 9 - Cover2
Clinical OMICs - Volume 3, Issue 9 - Contents
Clinical OMICs - Volume 3, Issue 9 - 4
Clinical OMICs - Volume 3, Issue 9 - 5
Clinical OMICs - Volume 3, Issue 9 - 6
Clinical OMICs - Volume 3, Issue 9 - 7
Clinical OMICs - Volume 3, Issue 9 - 8
Clinical OMICs - Volume 3, Issue 9 - 9
Clinical OMICs - Volume 3, Issue 9 - 10
Clinical OMICs - Volume 3, Issue 9 - 11
Clinical OMICs - Volume 3, Issue 9 - 12
Clinical OMICs - Volume 3, Issue 9 - 13
Clinical OMICs - Volume 3, Issue 9 - 14
Clinical OMICs - Volume 3, Issue 9 - 15
Clinical OMICs - Volume 3, Issue 9 - 16
Clinical OMICs - Volume 3, Issue 9 - 17
Clinical OMICs - Volume 3, Issue 9 - 18
Clinical OMICs - Volume 3, Issue 9 - 19
Clinical OMICs - Volume 3, Issue 9 - 20
Clinical OMICs - Volume 3, Issue 9 - 21
Clinical OMICs - Volume 3, Issue 9 - 22
Clinical OMICs - Volume 3, Issue 9 - 23
Clinical OMICs - Volume 3, Issue 9 - 24
Clinical OMICs - Volume 3, Issue 9 - 25
Clinical OMICs - Volume 3, Issue 9 - 26
Clinical OMICs - Volume 3, Issue 9 - 27
Clinical OMICs - Volume 3, Issue 9 - 28
Clinical OMICs - Volume 3, Issue 9 - 29
Clinical OMICs - Volume 3, Issue 9 - 30
Clinical OMICs - Volume 3, Issue 9 - 31
Clinical OMICs - Volume 3, Issue 9 - 32
Clinical OMICs - Volume 3, Issue 9 - 33
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss9
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss7
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss6
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss4
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss2
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss1
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss12
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss11
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss10
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss9
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss7
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss6
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss4
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss2
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss1
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue15
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue14
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue13
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue12
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue11
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue10
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue9
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue7
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue6
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue4
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue2
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue1
https://www.nxtbookmedia.com